Director Details

PuriCore plc

("PuriCore" or the "Company")

15 October 2013

Director Details

MALVERN, PENNSYLVANIA, AND STAFFORD, UK - PuriCore(LSE: PURI), a global company focused on safely and effectively protecting people from the spread of infectious pathogens, today announces that Charles Spicer has been named Executive Director of IXICO plc (LSE: IXI) as at 14 October 2013.

Enquiries:

About PuriCore

PuriCore plc (LSE: PURI) is a global company focused on safely and effectively protecting people from the spread of infectious pathogens without causing harm to human health or the environment. PuriCore's antimicrobial technology and complementary products are used principally in well-established core businesses and emerging sectors of two broad markets: Health Sciences and Food & Agriculture. In the Health Sciences market, PuriCore is the leading full provider of all products and services required for a safe, efficient, and compliant endoscope decontamination to protect patients in UK hospitals. PuriCore's breakthrough wound therapy solution is used to treat chronic and acute wounds including diabetic ulcers and burns as well as atopic dermatitis as dermatologic treatment products. In the Food & Agriculture market, PuriCore's portfolio provides savings to supermarket retailers in labour costs and improvements in inventory loss as well as addresses the issue of cross contamination of pathogens on fresh produce and floral products. In addition, the Company is progressing in its research and development programmes in the UK on the use of its technology as an agricultural fungicide. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK. To receive additional information on PuriCore, visit www.puricore.com.